BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33385072)

  • 1. Practical brachytherapy solutions to an age-old quandary.
    Thiruthaneeswaran N; Tharmalingam H; Hoskin PJ
    Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():39-47. PubMed ID: 33385072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
    Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
    Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate brachytherapy in the treatment of prostate cancer.
    Vicini F; Vargas C; Gustafson G; Edmundson G; Martinez A
    World J Urol; 2003 Sep; 21(4):220-8. PubMed ID: 12905008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high-dose rate brachytherapy in locally advanced prostate cancer.
    Vicini FA; Vargas C; Edmundson G; Kestin L; Martinez A
    Semin Radiat Oncol; 2003 Apr; 13(2):98-108. PubMed ID: 12728439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
    Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
    Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
    Hsu IC; Pickett B; Shinohara K; Krieg R; Roach M; Phillips T
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):851-8. PubMed ID: 10705005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Curative radiotherapy of localized prostate cancer. Treatment methods and results].
    Schwarz R
    Urologe A; 2003 Sep; 42(9):1212-20. PubMed ID: 14504754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose rate brachytherapy in the treatment of prostate cancer.
    Rodriguez RR; Demanes DJ; Altieri GA
    Hematol Oncol Clin North Am; 1999 Jun; 13(3):503-23. PubMed ID: 10432425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate surface brachytherapy to boost elongated, curvilinear incisional scars after extrapleural pneumonectomy for malignant pleural mesothelioma treated with adjuvant intensity-modulated radiation therapy.
    Doyle LA; Showalter TN; Werner-Wasik M; Weksler B; Xiao Y; Yu Y; Macrone A; Liu H; Harrison A
    Brachytherapy; 2010; 9(1):86-90. PubMed ID: 19846346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial.
    Palvai S; Harrison M; Shibu Thomas S; Hayden K; Green J; Anderson O; Romero L; Lodge R; Burns P; Ahmed I
    JMIR Res Protoc; 2015 Apr; 4(2):e49. PubMed ID: 25926023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic overview of radiation therapy effects in prostate cancer.
    Nilsson S; Norlén BJ; Widmark A
    Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy?
    Morton GC; Hoskin PJ
    Clin Oncol (R Coll Radiol); 2013 Aug; 25(8):474-82. PubMed ID: 23727431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of keloids by high-dose-rate brachytherapy: A seven-year study.
    Guix B; Henríquez I; Andrés A; Finestres F; Tello JI; Martínez A
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):167-72. PubMed ID: 11316560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.